However, in the current context and the highly controversial and controversial results of many studies, it is difficult to say about the clinical significance of the presence of mutations and chromosomal aberrations of the BRCA1, BRCA2, and PALB2 genes in a breast tumor and their impact on the effectiveness of chemotherapy and disease prognosis. Here, BRCA2 is linked to breast neoplasm.